Cookie Consent by PrivacyPolicies.com

Publicaciones científicas

94 Publicaciones científicas disponibles

  • CAV-2-Mediated GFP and LRRK2G2019S Expression in the Macaca fascicularis Brain

    25 de marzo de 2020 | Revista: Frontiers in Molecular Neuroscience

    di Caudo C (1,2), Martínez-Valbuena I (1,2,3), Mundiñano IC (1), Gennetier A (4), Hernandez M (1,3), Carmona-Abellan M (1,2), Marcilla Garcia I (1), Kremer EJ 4, Luquin R (1,2,3).

    (1) Division of Neuroscience, Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain.
    (2) Department of Neurology, Clinica Universidad de Navarra, Pamplona, Spain.
    (3) Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.
    (4) Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, Montpellier, France


  • Amylin as a potential link between type 2 diabetes and Alzheimer's disease

    3 de agosto de 2019 | Revista: Annals of Neurology

    Martinez-Valbuena I (1,2,3), Valenti-Azcarate R (1,2,3), Amat-Villegas I (3,4), Riverol M (1,3), Marcilla I (2,3), de Andrea CE (5), Sánchez-Arias JA (3,6), Del Mar Carmona-Abellan M (1,2,3), Marti G (1,3), Erro E (3,7), Martínez-Vila E (1,3), Tuñon MT (3,4), Luquin MR (1,2,3).

    (1) Neurology Department, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Regenerative Therapy Laboratory, Neurosciences Division, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
    (3) Navarra's Health Research Institute (IDISNA), Pamplona, Spain.
    (4) Pathology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
    (5) Pathology Department, Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Small Molecule Discovery Platform, Molecular Therapeutics Program, CIMA, University of Navarra, Pamplona, Spain.
    (7) Neurology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.


  • Cardiac sympathetic innervation in the MPTP non-human primate model of Parkinson disease

    23 de julio de 2019 | Revista: Clinical Autonomic Research

    Carmona-Abellan M (1), Martínez-Valbuena I (2,3), DiCaudo C (4), Marcilla I (2,3), Luquin MR (2,3,5)

    (1) Neurodegenerative Diseases Group, Neurosciences Division, Biocruces Bizkaia Health Research Institute, Plaza cruces s/n, 48903, Barakaldo, Vizcaya, Spain. mariadelmar.carmonaabellan@osakidetza.eus.
    (2) Neurosciences Division, Center for Applied Medical Research (CIMA), Pamplona, Navarra, Spain.
    (3) Idisna HRI, Pamplona, Navarra, Spain.
    (4) Neurology Section, Biomedical Center, Granada, Spain.
    (5) Neurology Department, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.


  • Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers

    5 de junio de 2019 | Revista: Parkinsonism Related Disorders

    Carmona-Abellan M (1), Gabilondo I (2), Murueta-Goyena A (3), Khurana V (4), Tijero B (5), Luquin MR (6), Acera M (1), Del Pino R (1), Gardeazabal J (7), Martínez-Valbuena I (6), Sanchez-Pernaute R (8), Gómez-Esteban JC (9)

    (1) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain.
    (2) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain; Ikerbasque: The Basque Foundation for Science, Bilbao, Spain.
    (3) Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain.
    (4) Ann Romney Center for Neurologic Disease, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
    (5) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain.
    (6) Department of Neurology, Clínica Universitaria de Navarra, Universidad de Navarra, Pamplona, Spain.
    (7) Dermatology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain.
    (8) Andalusian Initiative for Advanced Therapies, Junta de Andalusia, Seville, Spain.
    (9) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain

No hay más publicaciones científicas

No hay más páginas para cargar